Hematolymphoid neoplasms in effusion cytology
Vidya Monappa MD, DNB 1, Saritha M Reddy MD 2, Ranjini Kudva MD 1
1 Department of Pathology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India
2 Department of Pathology, St Johns Medical College, Bengaluru, Karnataka, India
|Date of Submission||26-Sep-2017|
|Date of Acceptance||23-Nov-2017|
|Date of Web Publication||14-Jun-2018|
Department of Pathology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka
Source of Support: None, Conflict of Interest: None
Background: Hematolymphoid neoplasms (HLNs) presenting as body cavity effusions are not a common finding. They may be the first manifestation of the disease. A diagnosis on effusion cytology may provide an early breakthrough for effective clinical management. Aims: Study the cytomorphology of HLNs in effusion cytology, determine common types, sites involved and uncover useful cytomorphologic clues to subclassify them. Materials and Methods: Twenty-four biopsy-proven HLN cases with malignant body cavity effusions and 8 cases suspicious for HLN on cytology but negative on biopsy are included in this study. Effusion cytology smears were reviewed for cytomorphological features: cellularity, cell size, nuclear features, accompanying cells, karyorrhexis, and mitoses. Results: Diffuse large B-cell lymphoma (37%) was the most common lymphoma type presenting as effusion followed by peripheral T-cell lymphoma (25%). Pleural effusion (75%) was most frequent presentation followed by peritoneal effusion (20.8%). Pericardial effusion was rare (4.1%). The common cytologic features of HLNs in effusions: high cellularity, lymphoid looking cells with nuclear enlargement, dyscohesive nature, and accompanying small lymphocytes. Mitosis and karyorrhexis were higher in high-grade HLNs when compared to low-grade HLNs. Myelomatous effusion showed plasmacytoid cells. Very large, blastoid looking cells with folded nuclei, high N: C ratio, and prominent nucleoli were seen in leukemic effusion. Conclusion: HLNs have characteristic cytomorphology and an attempt to subclassify them should be made on effusion cytology. Reactive lymphocyte-rich effusions cannot be distinguished from low-grade lymphomas based on cytomorphology alone. Ancillary tests such as immunocytochemistry, flow cytometry, and/or molecular techniques may prove more useful in this regard.
Keywords: Effusion cytology, leukemia, lymphocyte-rich effusion, lymphoma
|How to cite this article:|
Monappa V, Reddy SM, Kudva R. Hematolymphoid neoplasms in effusion cytology. CytoJournal 2018;15:15
To ensure the integrity and highest quality of CytoJournal publications, the review process of this manuscript was conducted under a double-blind model (authors are blinded for reviewers and vice versa) through automatic online system.
| » Introduction|| |
Hematolymphoid neoplasms (HLN) presenting as body cavity effusions is not a common finding. Very rarely, they can be the first sign of the disease. In decreasing order of frequency, this is observed in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma, Leukemias, and rarely in other myeloproliferative or myelodysplastic syndromes. They are different from primary effusion lymphomas (PELs) which do not involve any other site.
Malignant effusions in HLNs may be the first manifestation or may occur during the disease course. Effusion cytology is an easily available, inexpensive diagnostic tool in this setting. Cytomorphological features can provide useful information regarding the nature of the disease. Cell size, mitosis, etc., being valuable morphologic clues.
Aims and objectives
(1) The aim of this study is to study the cytomorphology of HLNs in effusion cytology, (2) To determine the most frequently encountered HLNs in effusion fluids, (3) To assess the affinity of HLNs to any particular sites (pleura/peritoneum), and (4) To determine the feasibility of subclassification of HLNs on effusion cytology.
| » Materials and Methods|| |
This is a retrospective study, wherein all cases of HLNs diagnosed on effusion cytology and with a biopsy confirmation during a 3-year period (June 2013– June 2016) are included in this study. The routine Pap-stained cytocentrifuge smears were reviewed for the following features: cellularity; cell size in comparison to that of small lymphocyte nucleus (SLN). They were categorized as small cell (1–1.5 times the SLN), large cell (2–2.5 times the SLN), and intermediate (between the two); nuclear features – chromatin, indentation, and nucleolus; cytoplasmic features – amount, granularity; background – small lymphocytes, mesothelial cells, tingible body macrophages. Other features were quantified as follows: karyorrhexis-minimal (+), moderate (++), abundant (+++), mitosis-rare (+), frequent (++), and brisk (+++).
Cell blocks were prepared from the residual fluid wherever available. The histomorphology on tissue biopsy and immunohistochemistry findings were studied in all cases.
| » Results|| |
A total of 32 cases were diagnosed as leukemia/lymphoma/suspicious for lymphoma on effusion cytology during this period. Of these 24 cases were confirmed to be malignant on histopathology and were included in this study. The remaining eight cases had a benign histopathology diagnosis and will be discussed separately.
Age ranged from 19 to 70 years with a mean age of 47 years. There were 14 males and 10 females with a male: female ratio of 1.4:1. Pleural effusion (19 cases) was the common presentation, followed by peritoneal (4), and pericardial effusion (1).
The various HLNs encountered in effusion cytology in this study are as depicted in [Table 1].
|Table 1: Hematolymphoid neoplasms in effusion cytology with sites involved and histopathology diagnosis (n=24)|
Click here to view
The details of the cases which were misdiagnosed on effusion cytology are as shown in [Table 2].
Diffuse large B-cell lymphoma
This was the most common lymphoma type presenting as effusion. The smears were cellular with >90% medium to large sized cells with large nucleus, coarse chromatin, one or more nucleoli, and moderate amount of cytoplasm [Figure 1]a. Brisk mitosis (+++) and prominent karyorrhexis (+++) were noted in all cases. Background occasional small lymphocytes were also noted.
|Figure 1: (a) Medium to large-sized lymphoid cells with nucleoli and brisk mitosis. Pap, ×200. Inset: Karyorrhexis, Pap, ×200. (b) Cell block showing small lymphoid cells with cleaved nuclei; admixed other cells seen. H and E, ×200. (c) Atypical plasmacytoid cells, binucleate cells, and mitosis. Pap, ×200. (d) Intermediate to large-sized “flower” cells (red arrow), Pap, ×400|
Click here to view
Small-sized lymphoid cells with cleaved nuclei, scant cytoplasm, and admixed reactive mesothelial cells were observed. Mitosis was uncommon (+), and karyorrhexis was absent [Figure 1]b.
Plasma cell myeloma
Sheets of plasmablasts and atypical plasma cells were noted. Frequent mitosis was noted (+++). Karyorrhexis was minimal (+) [Figure 1]c.
Peripheral T-cell lymphoma
Intermediate sized cells with deeply indented nucleus. Occasional “flower cells” with multilobate nuclei, admixed mesothelial cells, rare mitosis (+), and minimal karyorrhexis (+) were seen [Figure 1]d.
T-cell lymphoblastic lymphoma
Cellular smears with >95% intermediate sized lymphoid cells with delicate nuclear membrane, granular chromatin, inconspicuous nucleoli, and scant cytoplasm were observed. Occasional “Hand mirror' cells were also seen [Figure 2]a. Other cells were very rare. Mitosis (++) and moderate karyorrhexis (++) were seen.
|Figure 2: (a) Intermediate-sized lymphoid cells with delicate nuclear membrane, nuclear nicks (black arrow), and “hand mirror” cells (red arrow). Pap, ×200. (b) Very large cells, with a kidney-shaped, folded nucleus, fine chromatin, and single nucleolus. Pap, ×400. (c) Thick lymphocyte-rich smear, Pap, ×100. (d) Cellblock of a case of lymphocyte-rich effusion showing a polymorphous population of cells, H and E, ×200|
Click here to view
Acute myeloid leukemia
Smears showed >95% very large cells (>5 times the SLN) with enlarged irregular to kidney-shaped to folded nucleus with fine chromatin, single prominent nucleolus, and moderate cytoplasm. Occasional small lymphocytes, karyorrhexis (+), and rare mitosis (+) were also seen [Figure 2]b.
Lymphocyte-rich effusions misdiagnosed as suspicious for lymphoma
Cellular smears with reactive lymphocytes of near monomorphic sizes with an occasional mitosis was seen. No karyorrhexis was seen. Cellular crowding and thick smears were the contributing factors for misdiagnosis [Figure 2]c and [Figure 2]d.
| » Discussion|| |
Body cavity effusions may be the first presentation of HLNs or it may develop during the course of the disease (progression). However, PELs need to be ruled out. Pleural effusion as a complication of lymphomas has been reported in 20%–30% of cases., However, involvement of peritoneal and pericardial cavities is uncommon. Even rarer is the occurrence of malignant effusion in patients with acute leukemia/myeloma.
The mechanism of pleural effusion in these patients can be explained as follows: (1) Pleural infiltration by the neoplastic cells, (2) Lymphatic obstruction, (3) Obstruction of thoracic duct. Involvement of peritoneum/pericardium can also be explained along similar lines as follows: (1) Close proximity to the primary tumor, (2) Hematogenous dissemination, or (3) Widespread disease.
Malignancy in exudative effusions is more common than in transudative effusions (<8%). Other features such as elevated serum lactose dehydrogenase, serum protein levels, immunological defects, immature lymphocytes in peripheral blood, enlarged lymph nodes, hepatosplenomegaly are useful pointers to lymphomatous effusions.
Cytomorphological study of the neoplastic lymphoid/myeloid cells has not been extensively described in the literature. Diffuse large B-cell lymphomas (DLBCLs) show intermediate to large sized cells with enlarged nuclei, 1 or more prominent nucleoli with frequent mitosis. The authors observed prominent karyorrhexis and brisk mitoses in DLBCLs. Chen et al. observed that patients with DLBCL with lymphomatous effusions have a poor prognosis and need aggressive treatment like Stage IV disease. They also recommended effusion cytology as an essential additional workup in these patients; 18% of their cases had lymphomatous effusion.
Chen et al. opined that T-cell lymphoblastic leukemia/lymphoma should be deliberated in young patients with mediastinal mass with pleural effusion showing predominant small-to-medium-sized lymphoid cells with round-to-oval convoluted nuclei and fine chromatin with frequent mitosis and karyorrhexis. “Hand-mirror” cells have nuclear and cytoplasmic extensions involving one pole of the cell and had in the past been classically described in acute lymphoblastic leukemia. They have now also been observed in other lymphomas such as cutaneous natural killer cell lymphoma, Ki-1 lymphoma, Burkitt's lymphoma, B-Cell lymphomas with surface IgM-lambda, and with acute granulocytic/myelomonocytic leukemias.
Peripheral T-cell lymphoma (PTCL), NOS show monomorphic, intermediate-sized lymphoid cells with scant cytoplasm and irregular convoluted nuclear contours with some mimicking multilobate “flower cells.” Follicular lymphoma (FL) in effusion cytology shows small-sized lymphoid cells with cleaved nuclei. As was observed in our case, size is an important criteria to distinguish these two variants on morphologic grounds. In addition, accompanying cells– neutrophils, eosinophils are more common with PTCL than FL.
Acute and chronic leukemias rarely present as effusions. The presence of large-sized myeloblasts with enlarged indented nuclei, fine chromatin, 1 or more prominent nucleoli with moderate amount of lightly basophilic cytoplasm is a diagnostic pointer. These cells may be seen in clusters as well.
Myeloma presenting as pleural/peritoneal effusion is extremely rare. The presence of atypical plasma cells with dense cytoplasm, inconspicuous perinuclear hof, eccentric pleomorphic nuclei with coarse chromatin, and prominent nucleoli are useful diagnostic features. The authors also observed occasional binucleate cells.
Other subtypes of HLNs reported in literature include: Anaplastic large-cell lymphoma, with intermediate to large cells with irregular nuclei, RS-like cells, and cells with wreath-like arrangement of nuclei. Marginal zone lymphoma (MZL) shows small- to intermediate-sized cells with round nuclei. Plasmacytoid differentiation and emperipolesis are peculiar features described in MZL.,
Differential diagnosis includes reactive lymphocyte-rich effusions, other small round cell tumors, poorly differentiated adenocarcinoma, and PEL. Reactive lymphocyte-rich effusions can be cellular and very difficult to differentiate from low-grade lymphoma on cytomorphology alone. Immunocytochemistry (ICC) or flow cytometry studies may be useful in this regard as benign lymphocyte-rich effusions consist predominantly of T-cells. Other small round cell tumors such as small cell neuroendocrine tumors rarely involve peritoneal cavities. Poorly differentiated adenocarcinoma will show nuclear pleomorphism and at least focal acinar arrangement of cells. PEL is a rare type of NHL with involvement of serous cavities without lymphadenopathy. It affects immunosuppressed patients and human herpesvirus (HHV 8) is considered to be the etiological agent. This lymphoma is associated with a very poor prognosis. In all cases in this study, there was either nodal or bone marrow involvement thus ruling out possibility of PEL. The cells are large (2–2.5 times the size of SLN), with high N: C ratio, round to convoluted nuclei, coarse chromatin, with amphophilic to basophilic cytoplasm (plasmablastic); binucleate and multilobate nuclei are also seen.
Ancillary techniques such as – ICC, flow cytometry , or molecular studies can be readily performed on effusion specimens to overcome these diagnostic challenges. Cell blocks are excellent choices for immunocytochemical evaluation of effusions. The various benefits of cell blocks include – better standardization, easy morphologic interpretation similar to tissue sections, multiple sections for immunomarkers, and easy archiving. The SCIP (substractive coordinate immunoreactivity pattern) approach recommends an immunopanel (vimentin, pancytokeratin, leukocyte common antigen, calretinin and Wilms tumor 1) which can eliminate mesothelial and other inflammatory cells to recognize a “second-foreign” population of tumor cells. Furthermore, specific markers can be used subsequently.
| » Conclusion|| |
Cytologic analysis of HLNs in effusion fluids can provide a rapid diagnosis and provide an early breakthrough in patient management. The presence of HLNs in effusions is not only associated with poor patient outcome but is also a predictor of disease relapse after chemotherapy and decreased survival. Cytomorphologic features of HLNs provide useful information regarding the nature of disease – large cells with frequent mitosis and karyorrhexis (DLBCL) associated with aggressive clinical coarse while small cells with cleaved nucleus and rare mitosis seen in indolent lymphomas (FL). Leukemias show very large cells with folded nuclei. Atypical plasmacytoid cells are a pointer to myeloma/plasmablastic lymphoma. Attempt should be made to subclassify HLNs on effusion cytology. Well-spread smears and study of cell blocks (with ICC) can prove useful in avoiding false positives.
| » Competing Interests Statement by All Authors|| |
The authors have no competing interests.
| » Authorship Statement by All Authors|| |
Dr Vidya Monappa and Dr Saritha Reddy contributed in data collection, analyses and writing manuscript. Dr Ranjini Kudva edited the manuscript. All 3 authors were involved in conceptualizing the study.
| » Ethics Statement by All Authors|| |
This is a retrospective morphological study not directly involving patients.
| » List of Abbreviations (In Alphabetic Order)|| |
DLBCL - Diffuse large B cell lymphoma,
FL - Follicular lymphoma,
HHV8 - Human herpes virus 8,
HLN - Hematolymphoid neoplasm,
ICC - Immune cyto chemistry,
MZL - Marginal zone lymphoma,
NHL - Non Hodgkin lymphoma,
PEL - Primry effusion lymphoma,
PTCL - Peripheral T cell lymphoma,
SCIP - Substractive coordinate immunoreactivity pattern
SLN - Small lymphocyte nucleus.
| » References|| |
Sanchez SR, Chang CC. Hematolymphoid disorders. In: Shidham VB, Atkinson BF, editors. Cytopathologic Diagnosis of Serous Fluids. 1st
ed., Ch 12. Philadelphia, USA: Elsevier, W. B. Saunders Company; 2007. p. 171-93.
Berkman N, Breuer R, Kramer MR, Polliack A. Pulmonary involvement in lymphoma. Leuk Lymphoma 1996;20:229-37.
Manoharan A, Pitney WR, Schonell ME, Bader LV. Intrathoracic manifestations in non-Hodgkin's lymphoma. Thorax 1979;34:29-32.
Elis A, Blickstein D, Mulchanov I, Manor Y, Radnay J, Shapiro H, et al.
Pleural effusion in patients with non-Hodgkin's lymphoma: A case-controlled study. Cancer 1998;83:1607-11.
Chen HJ, Huang KY, Tseng GC, Chen LH, Bai LY, Liang SJ, et al.
Diagnostic pitfalls of discriminating lymphoma-associated effusions. Medicine (Baltimore) 2015;94:e800.
Das DK. Serous effusions in malignant lymphomas: A review. Diagn Cytopathol 2006;34:335-47.
Chen YB, Rahemtullah A, Hochberg E. Primary effusion lymphoma. Oncologist 2007;12:569-76.
Chen L, Zhang JS, Cui D, Liu DG. Cytological diagnosis of T lymphoblastic leukemia/Lymphoma in patients with pleural effusion as an initial clinical presentation: Two case reports of an algorithmic approach using complete immunohistochemical phenotyping. Acta Cytol 2015;59:485-92.
Siderits R, Godyn J, Tufankjian D, Ouattara O. T-cell lymphoproliferative disorder of hand-mirror cell morphology presenting in an eosinophilic loculated peritoneal effusion, with omental “caking”. Cytojournal 2006;3:13.
] [Full text]
Ameri MD, Parekh TM, Qian YW, Elghetany MT, Schnadig V, Nawgiri R, et al.
case of peripheral T-cell lymphoma, not otherwise specified in a HCV and HTLV-II-positive patient, diagnosed by abdominal fluid cytology. J Gastrointest Oncol 2016;7:S96-9.
Raina S, Kaul R, Mahesh DM, Kaushal SS, Gupta D, Sharma J. Pleural effusion in acute myeloid leukemia. J Assoc Physicians India 2008;56:914.
Palmer HE, Wilson CS, Bardales RH. Cytology and flow cytometry of malignant effusions of multiple myeloma. Diagn Cytopathol 2000;22:147-51.
Das DK, Chowdhury V, Kishore B, Chachra K, Bhatt NC, Kakar AK, et al.
CD-30(Ki-1)-positive anaplastic large cell lymphoma in a pleural effusion. A case report with diagnosis by cytomorphologic and immunocytochemical studies. Acta Cytol 1999;43:498-502.
Crapanzano JP, Lin O. Cytologic findings of marginal zone lymphoma. Cancer 2003;99:301-9.
Meykler S, Baloch ZW, Barroeta JE. A case of marginal zone lymphoma with extensive emperipolesis diagnosed on pleural effusion cytology with immunocytochemistry and flow cytometry. Cytopathology 2016;27:70-2.
Cakir E, Demirag F, Aydin M, Erdogan Y. A review of uncommon cytopathologic diagnoses of pleural effusions from a chest diseases center in Turkey. Cytojournal 2011;8:13.
] [Full text]
Ceran F, Aydin Y, Ozçakar L, Han U, Yildiz M. Primary effusion lymphoma: An untrivial differential diagnosis for ascites. Yonsei Med J 2009;50:862-4.
Wakely PE Jr., Menezes G, Nuovo GJ. Primary effusion lymphoma: Cytopathologic diagnosis using in situ
molecular genetic analysis for human herpesvirus 8. Mod Pathol 2002;15:944-50.
Yu GH, Vergara N, Moore EM, King RL. Use of flow cytometry in the diagnosis of lymphoproliferative disorders in fluid specimens. Diagn Cytopathol 2014;42:664-70.
Vejabhuti C, Chang CC. The flow cytometry, molecular analysis, and other special techniques. In: Shidham VB, Atkinson BF, editors. Cytopathologic Diagnosis of Serous Fluids. 1st
ed., Ch 13. Philadelphia, USA: Elsevier, W. B. Saunders Company; 2007. p. 195-205.
Shidham VB, Atkinson BF. Immunocytochemistry of effusion fluids: Introduction to the SCIP approach. In: Shidham VB, Atkinson BF, editors. Cytopathologic Diagnosis of Serous Fluids. 1st
ed., Ch. 5. Philadelphia, USA: Elsevier, W. B. Saunders Company; 2007. p. 55-78.
[Figure 1], [Figure 2]
[Table 1], [Table 2]